Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-20 Sale |
2022-12-22 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
15,360 | $38.11 | $585,387 | 2,080,871 (Indirect Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
5,000 | $37.48 | $187,416 | 11,644 (Direct) |
View |
| 2022-11-23 Sale |
2022-11-28 5:02 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
13,394 | $35.16 | $470,874 | 2,108,928 (Indirect Direct) |
View |
| 2022-11-22 Sale |
2022-11-23 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
600 | $35 | $21,001 | 1,979,528 (Indirect Direct) |
View |
| 2022-11-21 Sale |
2022-11-22 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
531 | $35.01 | $18,592 | 1,980,128 (Indirect Direct) |
View |
| 2022-11-15 Sale |
2022-11-17 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
1,115 | $35 | $39,028 | 1,980,659 (Indirect Direct) |
View |
| 2022-11-11 Sale |
2022-11-15 5:01 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
6,800 | $34.95 | $237,655 | 1,644 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-14 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
700 | $34.97 | $24,480 | 8,444 (Direct) |
View |
| 2022-08-22 Sale |
2022-08-23 5:16 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
5,000 | $35.98 | $179,900 | 87,220 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 5:15 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
14,690 | $34.01 | $499,651 | 1,833,154 (Indirect Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 4:27 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
17,302 | $34.03 | $588,752 | 1,857,026 (Indirect Direct) |
View |
| 2022-08-10 Sale |
2022-08-11 5:15 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
28,437 | $31.22 | $887,803 | 1,793,141 (Indirect Direct) |
View |
| 2022-08-09 Sale |
2022-08-10 5:25 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
39,431 | $31.15 | $1,228,276 | 1,821,578 (Indirect Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 5:25 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
117,907 | $31.46 | $3,709,403 | 1,861,009 (Indirect Direct) |
View |
| 2022-08-04 Sale |
2022-08-05 4:31 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
5,000 | $32.98 | $164,900 | 92,220 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-28 Exercise |
2022-12-30 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
8,722 | $7.9 | 110,453 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:01 pm |
2014-02-05 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
8,722 | $0 | 110,453 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-22 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
25,000 | $9.56 | 2,080,871 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-22 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
15,625 | $0 | 2,080,871 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-22 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
25,000 | $0 | 2,080,871 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
5,000 | $9.13 | 11,644 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:00 pm |
N/A 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
5,000 | $0 | 11,644 (Direct) |
View |
| 2022-11-23 Exercise |
2022-11-28 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
21,410 | $9.56 | 2,108,928 (Direct) |
View |
| 2022-11-23 Exercise |
2022-11-28 5:02 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
21,410 | $0 | 2,108,928 (Direct) |
View |
| 2022-11-22 Exercise |
2022-11-23 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
959 | $9.56 | 1,979,528 (Direct) |
View |
| 2022-11-22 Exercise |
2022-11-23 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
959 | $0 | 1,979,528 (Direct) |
View |
| 2022-11-21 Exercise |
2022-11-22 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
848 | $9.56 | 1,980,128 (Direct) |
View |
| 2022-11-21 Exercise |
2022-11-22 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
848 | $0 | 1,980,128 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
1,783 | $9.56 | 1,980,659 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
1,783 | $0 | 1,980,659 (Direct) |
View |
| 2022-11-11 Exercise |
2022-11-15 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
6,800 | $9.24 | 1,644 (Direct) |
View |
| 2022-11-11 Exercise |
2022-11-15 5:01 pm |
N/A 2024-01-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
6,800 | $0 | 1,644 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
700 | $9.24 | 8,444 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 5:00 pm |
N/A 2024-01-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
700 | $0 | 8,444 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-15 5:15 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
1,380 | $33.75 | 1,831,774 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-15 5:15 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
5,895 | $0 | 1,831,774 (Direct) |
View |
| 2022-08-22 Exercise |
2022-08-23 5:16 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
5,000 | $7.9 | 87,220 (Direct) |
View |
| 2022-08-22 Exercise |
2022-08-23 5:16 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
5,000 | $0 | 87,220 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 5:15 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
9,182 | $34.01 | 1,833,154 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 5:15 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
39,530 | $0 | 1,833,154 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 4:27 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
10,813 | $34.03 | 1,857,026 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 4:27 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
46,575 | $0 | 1,857,026 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-11 5:15 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
44,900 | $0 | 1,793,141 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-10 5:25 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
63,100 | $0 | 1,821,578 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:25 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
192,000 | $0 | 1,861,009 (Direct) |
View |
| 2022-07-15 Option Award |
2022-08-05 4:31 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
750 | $0 | 1,644 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-05 4:31 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
5,000 | $7.9 | 92,220 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-05 4:31 pm |
N/A 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
5,000 | $0 | 92,220 (Direct) |
View |
| 2022-03-18 Other |
2022-03-23 9:21 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
10,750 | $0 | 1,700,416 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-17 5:10 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
60,000 | $0 | 1,678,916 (Direct) |
View |
| 2022-02-22 Option Award(A) |
2022-02-25 5:17 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
21,000 | $0 | 108,220 (Direct) |
View |
| 2022-02-22 Option Award(A) |
2022-02-25 5:17 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
21,000 | $0 | 21,894 (Direct) |
View |
| 2022-02-22 Option Award(A) |
2022-02-25 5:15 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
21,000 | $0 | 28,444 (Direct) |
View |
| 2022-02-22 Option Award(A) |
2022-02-25 5:15 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
28,000 | $0 | 28,000 (Direct) |
View |
| 2022-02-22 Option Award(A) |
2022-02-25 5:14 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
27,000 | $0 | 27,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:29 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
250,000 | $0 | 1,868,916 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:27 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
21,000 | $0 | 21,894 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:26 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
21,000 | $0 | 28,444 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:26 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
10,729 | $0 | 90,904 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:25 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
27,000 | $0 | 27,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:24 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
10,729 | $0 | 20,162 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:24 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
28,000 | $0 | 28,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:24 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
10,729 | $0 | 32,992 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:23 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
10,729 | $0 | 112,460 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:22 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,729 | $0 | 20,162 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:22 pm |
N/A 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
21,000 | $0 | 108,220 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:20 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
4,222 | $0 | 101,731 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:19 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
4,222 | $0 | 9,433 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:17 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
4,222 | $0 | 9,433 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:16 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
4,222 | $0 | 22,263 (Direct) |
View |